Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway

It is generally known that glioblastoma is the most common primary malignant brain tumor and that it is highly aggressive and deadly. Although surgical and pharmacological therapies have made long-term progress, glioblastoma remains extremely lethal and has an uncommonly low survival rate. Therefore...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncol Rep
Huvudupphovsmän: Ke, Xiao-Xue, Pang, Yi, Chen, Kuijun, Zhang, Dunke, Wang, Feng, Zhu, Shunqin, Mao, Jingxin, Hu, Xiaosong, Zhang, Guanghui, Cui, Hongjuan
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2018
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196630/
https://ncbi.nlm.nih.gov/pubmed/30542699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2018.6777
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk